Page 3 - Patrick Wingrove News Today

Shares were off about 1% at $696.82 after gaining about 11% in January, making Lilly the eighth largest company in the U.S. by market capitalization and most valuable healthcare company.

(Reuters) -U.S. drug regulators in November found quality control lapses at the Bloomington, Indiana factory of contract drug manufacturer Catalent, including discovery of a "pest" on the manufacturing line, according to an inspection report. Novo Holdings, the parent company of Novo Nordisk, on Monday announced it was buying Catalent in a $16.5 billion deal that included its Bloomington plant, which it plans to sell to Novo Nordisk to help it produce its popular weight-loss drug Wego...

(Reuters) -U.S. drug regulators in November found quality control lapses at the Bloomington, Indiana factory of contract drug manufacturer Catalent, including discovery of a "pest" on the manufacturing line, according to an inspection report. Novo Holdings, the parent company of Novo Nordisk, on Monday announced it was buying Catalent in a $16.5 billion deal that included its Bloomington plant, which it plans to sell to Novo Nordisk to help it produce its popular weight-loss drug Wego...

By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN (Reuters) -Novo Nordisk will target launches of its popular obesity shot Wegovy in markets ...

Novo Nordisk will target launches of its popular obesity shot Wegovy in markets where it already has strong sales of its older weight-loss drug Saxenda, CEO Lars Fruergaard...

The World Health Organization (WHO) on Monday warned that global shortages last year of popular diabetes medicines that are also used for weight loss, such as Novo Nordisk's...

The World Health Organization (WHO) on Monday warned that global shortages last year of popular diabetes medicines that are also used for weight loss, such as Novo Nordisk's Ozempic, had been linked to rising reports of suspected counterfeits. The organization said fake versions of the drugs, which belong to a class called GLP-1 agonists, are most often sold and distributed through unregulated outlets, including social media platforms, and carry serious health risks. Explosive demand for ...

Three people sought medical treatment for dangerously low blood sugar in the U.S. last year after taking suspected fake versions of Novo Nordisks diabetes drug Ozempic, Americas Poison Centers told...

U.S. inspectors recently uncovered new manufacturing problems at an Eli Lilly plant that has been under scrutiny by federal investigators, according to government records obtained by Reuters....

U.S. inspectors recently uncovered new manufacturing problems at an Eli Lilly plant that has been under scrutiny by federal investigators, according to government records obtained by Reuters. ...